STRT · Strattec Security Corp

Shares withheld for payment of tax liability upon vesting of 12,618 shares of restricted stock; exempt under Rule 16b-3.

The price reported in this column reflects the weighted average purchase price of multiple trades executed through a broker-dealer at prices ranging from $62.22 to $62.715. Upon request, the reporting person will provide to the SEC staff, the Issuer, or any security holder of the issuer, detailed information regarding the number of shares purchased at each price.

Shares withheld for payment of tax liability upon vesting of 1,731 shares of restricted stock; exempt under Rule 16b-3.

Shares withheld for payment of tax liability upon vesting of 5,626 shares of restricted stock; exempt under Rule 16b-3.

Shares withheld for payment of tax liability upon vesting of 3,450 shares of restricted stock; exempt under Rule 16b-3.

The price reported in this column reflects the weighted average purchase price of multiple trades executed through a broker-dealer at prices ranging from $65.01 to $66.80. Upon request, the reporting person will provide to the SEC staff, the Issuer, or any security holder of the issuer, detailed information regarding the number of shares sold at each price.

Shares withheld for payment of tax liability upon vesting of 1,150 shares of restricted stock; exempt under Rule 16b-3.

Shares withheld for payment of tax liability upon vesting of 950 shares of restricted stock; exempt under Rule 16b-3.

This Form 4/A is being filed solely to correct the amounts of securities beneficially owned by the Reporting Person that were reported in Column 5 of Table I of the Form 4 filed on August 26, 2025. This correction has no effect on the transaction(s) previously reported.

Grant of shares of restricted stock which vest pro rata over three years on each anniversary of the grant date (i.e., one-third vest on each of August 22, 2026, August 22, 2027, and August 22, 2028).

Performance restricted stock units representing contingent rights to receive shares of the Issuer's Common Stock based upon the Issuer's EBITDA percentage over a three-year performance period ending July 2, 2028.

Performance restricted stock units representing contingent rights to receive shares of the Issuer's Common Stock based upon the Issuer's EBITDA percentage over a three-year performance period ending July 2, 2028.

Performance restricted stock units representing contingent rights to receive shares of the Issuer's Common Stock based upon the Issuer's EBITDA percentage over a three-year performance period ending July 2, 2028.

Shares withheld for payment of tax liability upon vesting of 1,150 shares of restricted stock; exempt under Rule 16b-3.

Shares withheld for payment of tax liability upon vesting of 950 shares of restricted stock; exempt under Rule 16b-3.

This Form 4/A is being filed solely to correct the amounts of securities beneficially owned by the Reporting Person that were reported in Column 5 of Table I of the Form 4 filed on August 26, 2025. This correction has no effect on the transaction(s) previously reported.

Grant of shares of restricted stock which vest pro rata over three years on each anniversary of the grant date (i.e., one-third vest on each of August 22, 2026, August 22, 2027, and August 22, 2028).

Shares of restricted stock which vest pro rata over a three year period on the anniversary of the date of grant (i.e., one-third vest on each of August 22, 2026, August 22, 2027, and August 22, 2028).

This Form 4/A is being filed solely to correct the amounts of securities beneficially owned by the Reporting Person that were reported in Column 5 of Table I of the Form 4 filed on August 26, 2025. This correction has no effect on the transaction(s) previously reported.

Grant of shares of restricted stock which vest pro rata over three years on each anniversary of the grant date (i.e., one-third vest on each of August 22, 2026, August 22, 2027, and August 22, 2028).

Shares withheld for payment of tax liability upon vesting of 1,150 shares of restricted stock; exempt under Rule 16b-3.

Shares withheld for payment of tax liability upon vesting of 950 shares of restricted stock; exempt under Rule 16b-3.

Shares withheld for payment of tax liability upon vesting of 12,618 shares of restricted stock; exempt under Rule 16b-3.

GAMCO Investors, Inc. and Associated Capital Group, Inc. have less than a 100% interest in this entity, GGCP, Inc. has less than a 100% interest in GAMCO Investors, Inc. and Associated Capital Group, Inc., and Mario J. Gabelli has less than a 100% interest in GGCP, Inc. The amount of securities reported as beneficially owned reflects the total amount of securities held by this entity which is greater than the Reporting Persons' indirect pecuniary interests. The Reporting Persons hereby disclaim ownership of these securities in excess of their pecuniary interests.

GAMCO Investors, Inc. and Associated Capital Group, Inc. have less than a 100% interest in this entity; GGCP, Inc. has less than a 100% interest in GAMCO Investors, Inc. and Associated Capital Group, Inc.; and Mario J. Gabelli has less than a 100% interest in GGCP, Inc. The amount of securities reported as beneficially owned reflects the total amount of securities held by this entity which is greater than the Reporting Persons' indirect pecuniary interests. The Reporting Persons hereby disclaim ownership of these securities in excess of their pecuniary interests.

GAMCO Investors, Inc. and Associated Capital Group, Inc. have less than a 100% interest in this entity; GGCP, Inc. has less than a 100% interest in GAMCO Investors, Inc. and Associated Capital Group, Inc.; and Mario J. Gabelli has less than a 100% interest in GGCP, Inc. The amount of securities reported as beneficially owned reflects the total amount of securities held by this entity which is greater than the Reporting Persons' indirect pecuniary interests. The Reporting Persons hereby disclaim ownership of these securities in excess of their pecuniary interests.

GAMCO Investors, Inc. and Associated Capital Group, Inc. have less than a 100% interest in this entity; GGCP, Inc. has less than a 100% interest in GAMCO Investors, Inc. and Associated Capital Group, Inc.; and Mario J. Gabelli has less than a 100% interest in GGCP, Inc. The amount of securities reported as beneficially owned reflects the total amount of securities held by this entity which is greater than the Reporting Persons' indirect pecuniary interests. The Reporting Persons hereby disclaim ownership of these securities in excess of their pecuniary interests.

Grant of shares of restricted stock which vest the later of (i) the 2025 annual meeting of shareholders of the Company or (ii) 50 weeks following the Grant Date.

Grant of shares of restricted stock which vest the later of (i) the 2025 annual meeting of shareholders of the Company or (ii) 50 weeks following the Grant Date.

Grant of shares of restricted stock which vest the later of (i) the 2025 annual meeting of shareholders of the Company or (ii) 50 weeks following the Grant Date.

Grant of shares of restricted stock which vest on the date of grant.

Grant of shares of restricted stock which vest in equal portions on on July 1, 2026 and July 1, 2027.

Grant of shares of restricted stock which vest on the date of grant.

Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's EBITDA percentage over a three-year performance period ending June 27, 2027.

Grant of shares of restricted stock which vest on the date of grant.

Grant of shares of restricted stock which vest the later of (i) the 2025 annual meeting of shareholders of the Company or (ii) 50 weeks following the Grant Date.

Grant of shares of restricted stock which vest on the date of grant.

Grant of shares of restricted stock which vest pro rata over three years on each anniversary of the grant date (i.e., one-third vest on each of October 25, 2025, October 25, 2026, and October 25, 2027).

Grant of shares of restricted stock which vest on July 1, 2025.

Grant of shares of restricted stock which vest the later of (i) the 2025 annual meeting of shareholders of the Company or (ii) 50 weeks following the Grant Date.